Suggest Clopidogrel Plus Aspirin in Most ACS Patients After a Coronary Stent

November 2017

You'll face questions about whether it's okay for patients to switch antiplatelets after a coronary stent.

Current guidelines prefer dual antiplatelet therapy with aspirin plus ticagrelor (Brilinta) or prasugrel (Effient, etc) after an acute coronary syndrome (ACS)...instead of aspirin plus clopidogrel (Plavix, etc).

Earlier studies suggest that ticagrelor or prasugrel reduces the risk of a recurrent CV event more than clopidogrel.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote